Concepta PLC (AIM: CPT), the personalised healthcare company, announces its interim results for the six months to 30 June 2020, a period of successful corporate reorganisation allowing additional funds to be channelled into product and commercial development of its home-use personalised fertility tracking and pregnancy self-testing system relaunched under the MYLO® brand.
Concepta PLC (AIM: CPT), the innovative UK personalised healthcare company and developer of myLotus®, the UK’s most accurate home-use fertility tracking and pregnancy self-testing system, announces final results for the year ended 31 December 2019.
Concepta (1.1p), the personalised healthcare company which has developed the proprietary self-test platform myLotus, has recently announced plans to raise new funds including the issue of new shares at 0.8p each
Concepta PLC (AIM: CPT), the innovative UK personalised healthcare company and developer of the proprietary self-test platform (“myLotus®”), the UK’s most accurate home-use fertility tracking and pregnancy testing system, announces a trading update.
Concepta Plc (AIM: CPT), the innovative UK personalised healthcare company and developer of the proprietary self-test platform (“myLotus®”) and suite of emerging test products targeting the mobile health market with a primary focus on women’s fertility and hormone health announces today its first pregnancies and user testimonials for the myLotus®monitor and app.
Concepta Plc (AIM: CPT), the innovative UK personalised healthcare company and developer of the proprietary self-test platform (“myLotus®”) and suite of emerging test products targeting the mobile health market, is pleased to announce it has agreed to supply the myLotus® product for women’s fertility and hormone testing to Boots UK, a member of Walgreens Boots Alliance.
Concepta plc (AIM: CPT) the UK healthcare company and developer of a proprietary product targeted at the mobile health market with a primary focus on women’s fertility, is pleased to announce that it has received Ethics Committee* approval to commence the user trial for its myLotus product in the UK.